BlackLine targets 7%-8% revenue growth in 2025 with new pricing model and SAP partnership focus
For Q1 2025, BlackLine projects revenue between $166M and $168M and non-GAAP operating margin of 16.5%-17.5%. Full-year 2025 revenue guidance stands at $699M to $705M, reflecting 7%-8% growth.
Exelixis targets $5B Zanza sales by 2033 with multiple pivotal trials in progress
CEO Mike Morrissey highlighted significant momentum in 2024, emphasizing the company's goal of achieving $3 billion in annual cabozantinib (Cabo) revenue by 2030 and $5 billion for zanzalintinib ...
Zacks.com on MSN3h
EXEL Tops Q4 Earnings and Sales, Cabometyx Label Expansion in Focus
Exelixis, Inc. EXEL reported better-than-expected fourth-quarter results. EXEL recorded earnings of 55 cents per share, which beat the Zacks Consensus Estimate of 51 cents. The company registered ...